Results of the ReCH-MIE 2025 call for proposals

Call for proposals for hospital-based clinical research projects devoted to emerging and re-emerging infectious diseases

Last updated on 17 November 2026

Main points

The ReCH-MIE call for proposals: hospital-based clinical research projects devoted to emerging and re-emerging infectious diseases

The ReCH-MIE call for proposals aims to support applied clinical research projects in hospital settings. It covers all emerging or re-emerging pathogens, including multidrug-resistant bacteria and fungi.

The call covers research applied to patient care and healthcare provision, with two main objectives:

  • Assessing the feasibility of an intervention aimed at improving patient care.
  • Assessing the safety, tolerability and efficacy of health technologies, particularly medicines and vaccines from phase I to phase IV, as well as any other medical intervention.

Discover the 11 laureates of ReCH-MIE 2025

Following the scientific assessment process, conducted by an independent expert committee led by ANRS MIE, 11 of the 23 eligible projects were recommended for funding by the expert committee, for a maximum total amount of €9,283,365.

ANRS MIE warmly thanks all the applicant teams, as well as the experts involved in this process.

Selected projects – Ministry of Health website

Project leader

Healthcare institution managing the funds

Project name

Project title

CAMBAU Emmanuelle

Greater Paris University Hospitals (AP-HP)

IDENOMY

Characterisation of immune deficiencies in patients with non-tuberculous mycobacterial (NTM) infection: a feasibility study

DE LA PORTE DES VAUX Clémentine

Greater Paris University Hospitals (AP-HP)

CAPSIDE

Pilot and feasibility study for detecting resistant or emerging skin-mediated infections and assessing health status among homeless adults in Paris.

DUVAL Xavier

Greater Paris University Hospitals (AP-HP)

REMAP-IE

A network-based adaptive platform for therapeutic trials in infective endocarditis

LE GOFF Jerome

Greater Paris University Hospitals (AP-HP)

VIR-HOST-PREDICT

Early prediction of complications of respiratory viral infections in immunocompromised patients

CHAÏBI Khalil

Greater Paris University Hospitals (AP-HP)

PACIFIC-VAP

Determinants of the transition from colonisation to Pseudomonas aeruginosa infection in ventilated intensive care patients

BOHARD Louis

Besançon University hospital

BioMEK

Relevance of novel biomarkers for monitoring cystic echinococcosis

KERNEIS Solen

Greater Paris University Hospitals (AP-HP)

SCORE

Impact of real-time genomic sequencing on controlling the transmission of emerging highly resistant bacteria (BHRe) in healthcare settings: a pragmatic cluster-randomised trial

ROQUILLY Antoine

Nantes University Hospital

SHAPe-IFIX

Infliximab for the treatment of severe hospital-acquired pneumonia at high risk of antibiotic-resistant bacteria: a phase II randomised, double-blind, placebo-controlled clinical trial, a component of the SHAPe factorial platform trial

MELICA Giovanna

Greater Paris University Hospitals (AP-HP)

TRANSVAC-RSV

Immunogenicity and safety of a booster vaccine dose 12 months after an initial dose of an mRNA or adjuvanted protein-based RSV pre-F vaccine in kidney transplant recipients: a phase II randomised, parallel-group superiority trial

GUEDJ Jérémie

Greater Paris University Hospitals (AP-HP)

BALOPEP

Efficacy of baloxavir prophylaxis against influenza virus transmission and influenza infection among nursing home residents

NOEL Nicolas

Greater Paris University Hospitals (AP-HP)

OptiViRes

Optimisation of care pathways for patients with respiratory viral infections through nasopharyngeal interferon phenotyping in primary care

Rech-MIE 2024 call for proposals

Discover the laureate projects from the previous edition.

2024 laureates